However, the penetrance of PAH is incomplete; only approximately 10–20% of individuals with BMPR2 variants develop the disease during their lifetime, suggesting that PAH development is triggered by other genetic or environmental factors [21,22]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.